Minerva Neurosciences Statistics
NASDAQ: NERVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.00-0.12 (-5.66%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Minerva Neurosciences by the numbers
Minerva Neurosciences has a market capitalization of $99.7 million based on 49.84M shares outstanding. With trailing EPS of $-33.83, Minerva Neurosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 28.6% below its 50-day average and 57.9% below its 200-day average.
Average daily trading volume is 164.71K shares, or about $329,424 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NERV valuation vs. peer median
| Metric | NERV | Peer median | Difference |
|---|---|---|---|
| Market cap | $99.67M | $98.28M | +1% |
| Avg. volume | 164.71K | 846.99K | -81% |
Peer median across 8 companies: ORGO, CNTN, UNCY, NBP, FHTX, GNLX, PDSB, NRXP.
Valuation
- Market cap
- $99.67M
- EPS (TTM)
- $-33.83
- Shares outstanding
- 49.84M
Price and trading
- Previous close
- 2.12
- Open
- 2.09
- Day range
- 1.99 – 2.12
- 52-week range
- 1.96 – 8.80
- 52-week change
- -49.24%
- Beta
- —
- Volume
- 137.66K
- Average volume
- 164.71K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 5, 2025
Additional statistics
- Market Cap
- 99.67M
- Forward Pe
- -4.76
- Eps
- -33.83
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 8.80
- Week52 Low
- 1.96
- Avg Volume
- 164.71K
- Shares Outstanding
- 49.84M
- Ma50
- 2.80
- Ma200
- 4.75
- Earnings Date
- Aug 5, 2025
- Pct From52w High
- -77.27%
- Pct From52w Low
- 2.04%